Search

everythinglearnresearchcommunity

for

Search:↓

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Computational methods help design drugs targeting prostate cancer proteins.

Genomics can improve patient care by using DNA to create personalized treatment plans.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Engineered protein hydrogels improve medical treatments by mimicking natural body structures.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

Forensic DNA phenotyping can help generate new leads in cold cases but faces accuracy, legal, and acceptance challenges.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Machine learning helps find new uses for existing drugs, improving healthcare.

A new model can predict drug-disease links well, helping drug research.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

These methods help understand cell structures and reactions.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.